A detailed history of Van Eck Associates Corp transactions in Medpace Holdings, Inc. stock. As of the latest transaction made, Van Eck Associates Corp holds 20,233 shares of MEDP stock, worth $7.05 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
20,233
Previous 14,452 40.0%
Holding current value
$7.05 Million
Previous $5.95 Million 12.2%
% of portfolio
0.01%
Previous 0.01%

Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

BUY
$320.58 - $457.29 $1.85 Million - $2.64 Million
5,781 Added 40.0%
20,233 $6.68 Million
Q2 2024

Jul 31, 2024

BUY
$372.0 - $424.34 $1.21 Million - $1.38 Million
3,251 Added 29.02%
14,452 $5.95 Million
Q1 2024

Apr 30, 2024

BUY
$284.87 - $413.31 $853,470 - $1.24 Million
2,996 Added 36.51%
11,201 $4.53 Million
Q4 2023

Feb 05, 2024

BUY
$227.52 - $312.68 $513,740 - $706,031
2,258 Added 37.97%
8,205 $2.52 Million
Q3 2023

Nov 08, 2023

BUY
$233.98 - $281.67 $417,186 - $502,217
1,783 Added 42.82%
5,947 $1.44 Million
Q2 2023

Aug 03, 2023

BUY
$187.26 - $240.17 $34,081 - $43,710
182 Added 4.57%
4,164 $1 Million
Q1 2023

May 03, 2023

BUY
$174.31 - $239.52 $512,994 - $704,907
2,943 Added 283.25%
3,982 $749,000
Q4 2022

Feb 08, 2023

BUY
$153.06 - $226.57 $26,326 - $38,970
172 Added 19.84%
1,039 $221,000
Q3 2022

Oct 27, 2022

BUY
$145.13 - $182.49 $11,320 - $14,234
78 Added 9.89%
867 $136,000
Q2 2022

Aug 03, 2022

BUY
$130.2 - $168.03 $2,213 - $2,856
17 Added 2.2%
789 $118,000
Q1 2022

May 10, 2022

BUY
$138.87 - $214.31 $14,720 - $22,716
106 Added 15.92%
772 $126,000
Q4 2021

Jan 26, 2022

BUY
$182.74 - $227.9 $10,598 - $13,218
58 Added 9.54%
666 $145,000
Q3 2021

Nov 03, 2021

BUY
$170.18 - $198.21 $38,460 - $44,795
226 Added 59.16%
608 $115,000
Q2 2021

Aug 10, 2021

BUY
$158.62 - $194.3 $60,592 - $74,222
382 New
382 $67,000

Others Institutions Holding MEDP

About Medpace Holdings, Inc.


  • Ticker MEDP
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 31,099,900
  • Market Cap $10.8B
  • Description
  • Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, bi...
More about MEDP
Track This Portfolio

Track Van Eck Associates Corp Portfolio

Follow Van Eck Associates Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Van Eck Associates Corp, based on Form 13F filings with the SEC.

News

Stay updated on Van Eck Associates Corp with notifications on news.